Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Exchange Rate Effect (2023 - 2025)

Rein Therapeutics (RNTX) has disclosed Exchange Rate Effect for 3 consecutive years, with -$26000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect changed N/A to -$26000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$90000.0, a N/A change, with the full-year FY2023 number at -$63000.0, changed N/A from a year prior.
  • Exchange Rate Effect was -$26000.0 for Q3 2025 at Rein Therapeutics, down from -$1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of -$1000.0 in Q4 2024 to a low of -$63000.0 in Q4 2023.
  • A 3-year average of -$30000.0 and a median of -$26000.0 in 2025 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 98.41% in 2024; the steepest drop was 98.41% in 2024.
  • Rein Therapeutics' Exchange Rate Effect stood at -$63000.0 in 2023, then soared by 98.41% to -$1000.0 in 2024, then tumbled by 2500.0% to -$26000.0 in 2025.
  • Per Business Quant, the three most recent readings for RNTX's Exchange Rate Effect are -$26000.0 (Q3 2025), -$1000.0 (Q4 2024), and -$63000.0 (Q4 2023).